AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CareGeographicals
NephrectomyLaparoscopyKidney NeoplasmsRoboticsCarcinoma, Renal CellRetroperitoneal SpaceHemostasis, SurgicalKidneyPeritoneumRecurrenceOrgan Sparing TreatmentsNeoplasm Recurrence, LocalTreatment OutcomeLaparoscopesWarm IschemiaBlood Loss, SurgicalRetrospective StudiesNephronsKidney PelvisPostoperative ComplicationsPoloxamerUrinomaKidney DiseasesChyleSurgery, Computer-AssistedUreteral ObstructionPneumothorax, ArtificialElectrocoagulationTime FactorsOperative TimeOperating RoomsKidney TransplantationUrologySurgical InstrumentsRenal ArteryBufanolidesLearning CurveLymphoceleFollow-Up StudiesDiuretics, OsmoticSurgically-Created StructuresAortic Aneurysm, AbdominalKidney Function TestsAorta, AbdominalVascular Surgical ProceduresFeasibility StudiesAdrenalectomyAdenoma, OxyphilicTomography, X-Ray ComputedLength of StayAngiomyolipomaAnastomosis, SurgicalAsphyxiaAdrenal Gland NeoplasmsUrologic Surgical ProceduresIohexolGlomerular Filtration RateHand-Assisted LaparoscopyConstrictionIntraoperative ComplicationsDialysis SolutionsIliac ArteryLiving DonorsLaser TherapyKidney TubulesKidney Failure, ChronicBlood Vessel Prosthesis ImplantationPeritoneal DialysisNational Cancer Institute (U.S.)Acute Kidney InjuryKidney CortexNeoplasm StagingKidney GlomerulusProspective StudiesReoperationSurvival RateTissue and Organ HarvestingEquipment DesignPyelonephritis, XanthogranulomatousPolycystic Kidney DiseasesSwineUreterPrognosisCreatinineRenal VeinsKidney Tubules, ProximalSEER ProgramKidney CalculiUremiaKidney MedullaPolycystic Kidney, Autosomal DominantProteinuriaUnited States
Postoperative recurrenceRadicalTumorInferior venaLaparoscopicAdrenalectomyBladderSolitary kidneySurgicalRenalBiopsyPathologyInvasionApproximatelyDiseaseIncludeTypeRadical nephrectomyRobotic Partial NephrectomyRobot-assisted partial nephrectomyOpen partial nephrectomyLaparoscopic transperitonealPostoperativeSolitary KidneyMetastasisMalignant tumorsRetroperitonealDonorPredictApproachesOutcomesClinicalChronicPatientsWashington UniversityApproachTreatmentSimpleSurgeryCommon
Postoperative recurrence1
  • Besides, to prevent postoperative recurrence, systemic therapy should be applied, though the investigation is still ongoing. (bvsalud.org)
Radical9
  • Wilms tumor, treatment for which includes surgery (radical or partial nephrectomy), is the fifth most common pediatric malignancy and the most common type of renal tumor in children. (medscape.com)
  • According to the NWTSG protocol, the first step in the treatment of Wilms tumor is surgical staging followed by radical nephrectomy, if possible. (medscape.com)
  • Although end-stage kidney disease after unilateral radical nephrectomy is uncommon (0.25% in the NWTSG trial), preserving healthy kidney tissue may prevent this complication, especially in patients with an underlying intrinsic kidney disease (eg, WAGR [Wilms tumor, aniridia, genitourinary anomalies, and mental retardation] syndrome, Denys-Drash syndrome). (medscape.com)
  • For high-risk UTUC cases with a normal contralateral kidney, radical nephroureterectomy is the standard treatment. (bvsalud.org)
  • Radical nephrectomy is the standard for larger and central tumors. (medscape.com)
  • Robotic surgery has gained significant traction in a variety of urologic procedures, including radical and simple prostatectomy, partial nephrectomy, and recently radical cystectomy. (basicmedicalkey.com)
  • To explore the feasibility of single-position laparoscopic radical nephrectomy (LRN) and tumor thrombectomy for left renal cell carcinoma with high-risk Mayo 0 and 1 tumor thrombus (TT). (biomedcentral.com)
  • Studies have shown that radical nephrectomy and inferior vena cava TT removal for patients with locally advanced renal cancer can effectively improve the prognosis, and the 5-year tumor-specific survival rate is 40-65% [ 2 ]. (biomedcentral.com)
  • The aim of the study was to explore the feasibility of single position transperitoneal laparoscopic radical nephrectomy (LRN) and high-risk Mayo 0 and 1 tumor thrombectomy and the surgical techniques were described in detail. (biomedcentral.com)
Tumor9
  • Gross nephrectomy specimen shows a Wilms tumor pushing the normal renal parenchyma to the side. (medscape.com)
  • Indications for primary surgical excision of a Wilms tumor include tumors confined to the kidney, extending beyond the kidney but not crossing the midline, and with or without vascular extension. (medscape.com)
  • In all, the utilization of ureteroscopic retrograde tumor ablation, BCG bladder instillation, and tislelizumab injection to treat high-risk ureteral carcinoma for kidney-sparing therapy have filled in the gap in this field, which should be promoted to help more patients in similar situations. (bvsalud.org)
  • T4: Tumor invades adjacent organs or through the kidney into perinephric fat. (urology-textbook.com)
  • It is feasible to control left renal vein and partial inferior vena cava through descending colon mesentery in a single position during LRN and tumor thrombectomy for the treatment of high-risk Mayo grade 0 and 1 TT. (biomedcentral.com)
  • Case 1 imaging examination revealed a left kidney tumor with venous TT (Mayo stage 1) and multiple lung metastases. (biomedcentral.com)
  • The imaging examinations of case 2 showed a left kidney tumor with venous TT (Mayo grade 1), accompanied by left adrenal gland metastasis. (biomedcentral.com)
  • The imaging examination of case 3 showed left kidney tumor with retroperitoneal lymphadenopathy, left renal vein TT (Mayo grade 0) and multiple lung metastases. (biomedcentral.com)
  • The outcomes analyzed included operative time, blood loss, surgical complications, average length of hospital stay, conversion to open surgery & tumor recurrence. (amegroups.org)
Inferior vena2
  • If it is a high-risk Mayo grade 0 TT or even grade 1 TT, traditionally two steps were utilized including management of the inferior vena cava and removement of the TT, and then nephrectomy after changing the surgical position. (biomedcentral.com)
  • There is also potential risk of injury to adjacent structures including kidney, liver, spleen, pancreas, inferior vena cava and bowel. (amegroups.org)
Laparoscopic2
  • In recent years, robot-assisted/laparoscopic surgery has become the first choice for the treatment of kidney cancer with venous TT for minimal invasion. (biomedcentral.com)
  • Retroperitoneal laparscopic adrenalectomy (RPLA) or transperitoneal laparoscopic adrenalectomy (TPLA) was found to be safe and effective for large tumours (≥5 cm) when compared to open adrenalectomy (OA). (amegroups.org)
Adrenalectomy2
  • Reports in the literature have shown that open adrenalectomy compared to LA has better overall survival and recurrence-free survival. (basicmedicalkey.com)
  • Current contraindications for LA are adrenocortical carcinomas (ACC) with radiographic evidence of tumour invasion, recurrence of tumour after prior adrenalectomy and severe cardiopulmonary disease ( 4 ). (amegroups.org)
Bladder2
Solitary kidney2
  • In patients with bilateral Wilms tumors, solitary kidney, or kidney insufficiency, partial nephrectomy is a reasonable consideration. (medscape.com)
  • As for low-risk UTUC cases or solitary kidney cases, kidney-sparing therapy may be a better choice. (bvsalud.org)
Surgical1
  • Underinsurance And Multiple Surgical Treatments for Kidney Stones. (ucsf.edu)
Renal5
  • Descriptive statistics with median and interquartile range (IQR) for continuous variables and numbers with frequencies for categorical variables were used to report perioperative and renal function outcomes while Kaplan-Meier curves were computed to present extravesical and intravesical recurrence-free survival(RFS) as well as cancer-specific (CSS) and overall survival (OS) with the corresponding 95% confidence intervals(CIs). (bvsalud.org)
  • Renal cell carcinoma (see the image below) is the most common type of kidney cancer in adults. (medscape.com)
  • Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney. (medscape.com)
  • The kidney biopsy confirmed clear renal cell carcinoma with poorly differentiated and accompanied by necrosis. (biomedcentral.com)
  • The pathology from kidney biopsy demonstrated clear renal cell carcinoma and the patient received 2 cycles of axitinib for neoadjuvant treatment. (biomedcentral.com)
Biopsy1
  • If imaging studies demonstrate bilateral disease, nephrectomy is not performed, but biopsy specimens are obtained. (medscape.com)
Pathology1
  • Therapeutic Living Donor Nephrectomy For Proximal Ureteral Pathology: A Longitudinal Case Series. (ucsf.edu)
Invasion1
  • Invasion of the venous system is one of the clinical features of locally advanced kidney cancer. (biomedcentral.com)
Approximately1
  • 1] It accounts for approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney. (medscape.com)
Disease1
  • In this case report, we reported a rare case diagnosed with high-risk ureteral carcinoma, but he underwent kidney-sparing therapy due to chronic kidney disease. (bvsalud.org)
Include1
  • This review should include oncologic issues, kidney function issues, and potential complications. (medscape.com)
Type1
  • A Case Report of Kidney-Only Transplantation in Primary Hyperoxaluria Type 1: A Novel Approach with the Use of Nedosiran. (ucsf.edu)
Radical nephrectomy6
Robotic Partial Nephrectomy1
  • 18. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. (nih.gov)
Robot-assisted partial nephrectomy2
  • 11. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience. (nih.gov)
  • BACKGROUND: For patients with prior intra-abdominal surgery or multiple arteries, the retroperitoneal robot-assisted partial nephrectomy (rRAPN) is a better choice. (bvsalud.org)
Open partial nephrectomy1
  • This case study concerns a patient with an incidentally discovered small renal cortical tumor who underwent open partial nephrectomy. (medscape.com)
Laparoscopic transperitoneal2
  • In this case study diagnostic work-up and management with laparoscopic transperitoneal dismembered Anderson-Hynes pyeloplasty is described. (medscape.com)
  • We retrospectively compared laparoscopic transperitoneal and retroperitoneal approaches for the decor-tication of simple renal cysts with respect to safety, postoperative pain, and clinical results. (ac.ir)
Postoperative1
  • The ITT group (20 patients), which improved the tumor exposure by traction of the kidney with suture, was compared with the traditional technique group (8 patients) in terms of warm ischemia time, estimated blood loss and postoperative hospital stay, retroperitoneal drainage, R.E.N.A.L. score, and serum creatinine. (bvsalud.org)
Solitary Kidney1
  • 16. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis. (nih.gov)
Metastasis2
  • These tumors tend to be smaller and of lower stage, resulting in better survival rates, lower recurrence rates, and lower metastasis rates than RCC detected in symptomatic patients. (medscape.com)
  • After 10 months of follow-up, no recurrence or metastasis occurred in all cases. (bvsalud.org)
Malignant tumors2
  • The American Cancer Society estimates that in 2022 there will be 79,000 cases (50,290 in males and 28,710 in females) of malignant tumors of the kidney and renal pelvis diagnosed, with 13,920 deaths (8960 in males and 4960 in females). (medscape.com)
  • Clear cell renal cancer is the most common type of kidney cancer, comprising 80 percent of all malignant tumors found within the kidney. (nih.gov)
Retroperitoneal2
  • The mean age of the patients were 54.65 ± 5.26 years in the retroperitoneal group and 56.0 ± 4.66 years in the transperitoneal group. (ac.ir)
  • 05). According to VAS scale, the retroperitoneal scoring method was found to be lower than the transperitoneal scoring method. (ac.ir)
Donor3
  • Minilaparoscopy vs. standard laparoscopic donor nephrectomy: compari¬son of safety, efficacy and cosmetic outcomes in a randomized clinical trial. (ac.ir)
  • This study was conducted to compare safety, efficacy and cosmetic outcome between standard laparoscopic live donor nephrectomy (sLDN) and mini-laparoscopic donor nephrectomy (mLDN) in a randomized clinical trial. (ac.ir)
  • From March 2012 to June 2013, 100 consecutive kidney donors were randomly assigned to two equal groups for laparoscopic donor nephrectomy. (ac.ir)
Predict1
  • METHODS: In this retrospective analysis and validation study, we developed a histopathological whole-slide image (WSI)-based score using deep learning allied to digital scanning of conventional haematoxylin and eosin-stained tumour tissue sections, to predict tumour recurrence in a development dataset of 651 patients with distinctly good or poor disease outcome. (bvsalud.org)
Approaches1
  • Nephrectomy has many indications, for both simple and radical approaches. (medscape.com)
Outcomes5
  • 1. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy. (nih.gov)
  • 2. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. (nih.gov)
  • 7. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. (nih.gov)
  • 13. Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes. (nih.gov)
  • 17. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. (nih.gov)
Clinical3
  • 10. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis. (nih.gov)
  • We developed a novel assay integrating three modalities-clinical, genomic, and histopathological-to improve the predictive accuracy for localised renal cell carcinoma recurrence. (bvsalud.org)
  • At the end of six months, no clinical and radiological recurrence was detected in any patient. (ac.ir)
Chronic2
  • A simple nephrectomy is indicated in patients with irreversible kidney damage due to symptomatic chronic infection, obstruction, calculus disease, or severe traumatic injury. (medscape.com)
  • Chronic kidney disease, renal transplantation, hemodialysis, acquired cystic kidney disease, a history of previous renal cell carcinoma, and co-existing diabetes mellitus have been recognized as potential risk factors associated with an increase in incidence in renal cell carcinoma in population-based studies. (nih.gov)
Patients3
  • BACKGROUND: Improved markers for predicting recurrence are needed to stratify patients with localised (stage I-III) renal cell carcinoma after surgery for selection of adjuvant therapy. (bvsalud.org)
  • The six single nucleotide polymorphism-based score, which was detected in paraffin-embedded tumour tissue samples, and the Leibovich score, which was established using clinicopathological risk factors, were combined with the WSI-based score to construct a multimodal recurrence score in the training dataset of 1125 patients. (bvsalud.org)
  • The multimodal recurrence score was validated in 1625 patients from the independent validation dataset and 418 patients from The Cancer Genome Atlas set. (bvsalud.org)
Washington University1
Approach1
Treatment1
  • 1869: Gustav Simon performs the first planned nephrectomy for the treatment of ureterovaginal fistula. (medscape.com)
Simple1
  • Simple nephrectomy is also indicated to treat renovascular hypertension due to noncorrectable renal artery disease or severe unilateral parenchymal damage caused by nephrosclerosis, pyelonephritis, reflux dysplasia, or congenital dysplasia of the kidney. (medscape.com)
Surgery1
Common2
  • Currently, cancers of the kidney and renal pelvis are the sixth most common cancer in US men, accounting for 5% of cases, and the ninth most common in US women, accounting for 3% of cases. (medscape.com)
  • Renal cell carcinoma, of which clear cell carcinoma is the most common histological subtype (80 to 90 percent), comprises 90 percent of all Kidney tumors. (nih.gov)